Suresh Vellingiri | Matrix Composites | Pioneer Researcher Award

Dr. Suresh Vellingiri | Matrix Composites | Pioneer Researcher Award

Associate Professor | Kalaignar karunanidhi Institute of Technology | India

Dr. Suresh Vellingiri is a distinguished academic and researcher in the field of Mechanical Engineering, currently serving as an Associate Professor at KIT–Kalaignarkarunanidhi Institute of Technology, Coimbatore. He holds a Ph.D. in Mechanical Engineering from Anna University, obtained in 2014, along with an M.E. in Engineering Design and a B.E. in Mechanical Engineering, both with first-class distinction. With over two decades of academic and research experience, including 11 years post-Ph.D., Dr. Vellingiri has made notable contributions in materials and manufacturing processes, composite materials, CAD/CAM, FEA, and additive manufacturing technologies. His doctoral research focused on the mechanical testing and machining parameter analysis of LM25 aluminium hybrid metal matrix composites reinforced with boron carbide and graphite. A recognized research supervisor under Anna University, he has published extensively in reputed journals, achieving over 970 citations with an h-index of 13 and i10-index of 16. His research includes innovative works on intelligent control systems, solar energy applications, and biofuels with nano-additives. Beyond research, Dr. Vellingiri has played several academic leadership roles, including Research Coordinator, NBA/NAAC Criteria Coordinator, and International Conference Organizer at various engineering institutions. His consistent efforts in promoting academic excellence, mentoring young researchers, and integrating modern design and manufacturing concepts into education exemplify his dedication to advancing engineering science and technology. Through his scholarly impact, leadership, and research innovation, Dr. Vellingiri continues to be a driving force in the evolving field of mechanical and manufacturing engineering.

Profile:  ORCID Google Scholar

Featured Publications

  • Perundyurai, T. S., Vellingiri, S., Rajendrian, S., Munusamy, S., & Chinnaiyan, S. (2020). K-nearest neighbour technique for the effective prediction of refrigeration parameter compatible for automobile. Thermal Science, 24(1 Part B), 565–569.

  • Vigneshkumar, N., Venkatasudhahar, M., Kumar, P. M., Ramesh, A., Subbiah, R., & Vellingiri, S. (2021). Investigation on indirect solar dryer for drying sliced potatoes using phase change materials (PCM). Materials Today: Proceedings, 47, 5233–5238.

  • Vasanthaseelan, S., Kumar, P. M., Anandkumar, R., Ram, K. H., Subbiah, R., & Vellingiri, S. (2021). Investigation on solar water heater with different types of turbulators. Materials Today: Proceedings, 47, 5203–5208.

  • Saravankumar, P. T., Suresh, V., Vijayan, V., & Godwin Antony, A. (2019). Ecological effect of corn oil biofuel with SiO₂ nano-additives. Energy Sources, Part A: Recovery, Utilization, and Environmental Effects, 41, 1–10.

  • Sathish Kumar, A., Naveen, S., Vijayakumar, R., Suresh, V., Asary, A. R., & Others. (2023). An intelligent fuzzy-particle swarm optimization supervisory-based control of robot manipulator for industrial welding applications. Scientific Reports, 13(1), 8253.

Yufeng Xing | Composite Materials Science | Best Researcher Award

Prof Dr. Yufeng Xing | Composite Materials Science | Best Researcher Award

Professor at Shenzhen Traditional Chinese Medicine Hospital, China

Profile:

Current Position🏥

Professor Yufeng Xing, M.D., is a prominent figure in the field of liver disease research, holding several key roles in prestigious medical institutions. He serves as the Director of the Department of Liver Disease at the Shenzhen Traditional Chinese Medicine (TCM) Hospital. Additionally, he leads the National Key Specialized and Key Discipline Research Office of Hepatology of TCM. His influence extends further as the Deputy Director of the South China Center for TCM Liver Disease Diagnosis and Treatment under the State Administration of TCM. His academic affiliations include his role as the head of the Institute of Liver Disease at the Fourth Clinical College of Guangzhou University of TCM.

In recognition of his expertise, Professor Xing has been named a Guangdong Outstanding Young Medical Talent, a Shenzhen Chinese Medicine Leading Talent, and a Shenzhen High-Level Talent. Moreover, he is part of the Shenzhen Health Committee Elite Talent Program as a subject leader for training, showcasing his growing influence in medical education and research.

Publication Achievements📚

Professor Xing has an extensive body of work, with over 40 academic papers published, including 15 SCI-indexed papers. His research has made a significant impact in the field of liver diseases, particularly with his studies focusing on viral hepatitis, metabolic-associated fatty liver disease (MAFLD), cirrhosis, and liver cancer. His collaborative and individual contributions have resulted in eight national and provincial science and technology achievement awards and the authorship of three monographs. These publications have garnered recognition from both domestic and international communities, further solidifying his reputation as a leading expert in liver disease and TCM.

Ongoing Research🔬

Professor Xing’s ongoing research is centered on leveraging Traditional Chinese Medicine in the fight against liver diseases. His work spans several critical areas:

  • Viral hepatitis, MAFLD, cirrhosis, and liver cancer: His research focuses on understanding and treating these conditions through innovative TCM approaches.
  • Application of network pharmacology and bioinformatics: He utilizes cutting-edge techniques such as network pharmacology and bioinformatics to explore the prevention and treatment of liver diseases with TCM, aiming to improve therapeutic outcomes.
  • Biomaterials and nanocarriers: His work also delves into the innovation, research, and development of biomaterials and nanocarriers for targeted treatment of liver diseases, representing a promising future direction in both Western and Chinese medicine.

Research Interests🔍

Professor Xing’s primary research interests lie in the intersection of Traditional Chinese Medicine and modern biomedical technology. His expertise in liver diseases, particularly viral hepatitis and liver cancer, highlights his commitment to integrating ancient medical knowledge with modern scientific discoveries. Moreover, his focus on the application of network pharmacology and bioinformatics in liver disease prevention through TCM opens new possibilities in personalized medicine. His research in biomaterials and nanocarriers further showcases his innovative mindset, blending material science and medical science for breakthrough treatments.

Academic Background🎓

Professor Xing’s distinguished career is underpinned by a strong academic foundation. His journey through the fields of medicine and traditional Chinese medicine has been marked by continual learning and research excellence. As a doctoral supervisor and postdoctoral cosupervisor, he plays an active role in shaping the next generation of scholars and medical professionals, further advancing TCM as a modern and respected discipline.

Scholarships and Awards🏆

Throughout his career, Professor Xing has earned numerous accolades, affirming his contributions to medical science and education. Among his most notable recognitions are his awards from provincial and national bodies for his scientific achievements. His leadership roles in prestigious medical and research institutions are a testament to his contributions, with awards like the Shenzhen Chinese Medicine Leading Talent highlighting his influence in the field.

Bioinformatics💻

Professor Xing has integrated bioinformatics into his research on liver diseases, particularly within the context of Traditional Chinese Medicine. Through network pharmacology approaches, he identifies key molecular mechanisms and potential therapeutic targets for liver disease. This innovative use of bioinformatics has enabled Professor Xing to predict the interactions between herbal compounds and biological systems, opening up new possibilities for the prevention and treatment of complex liver diseases.

Professional Associations🌐

Professor Xing is actively involved in various professional organizations. He serves as the Vice President and Secretary General of the East China Southern TCM Liver Disease Alliance, and as Deputy Secretary General of the Hepatology Branch of the Chinese Society of Ethnic Medicine. He is also a standing member of several other important bodies, including the Hepatobiliary Diseases Branch of the Chinese Association of Traditional Chinese Medicine and the Executive Director of the Infectious Diseases Branch of the Chinese Society of Ethnic Medicine. His involvement in these organizations reflects his leadership in promoting liver disease research and treatment, particularly through the lens of Traditional Chinese Medicine.

Training & Workshops🏅

In his dedication to knowledge dissemination, Professor Xing actively participates in and conducts training programs and workshops. These events focus on advancements in liver disease treatments and Traditional Chinese Medicine. His mentorship extends to both aspiring researchers and established professionals, bridging the gap between ancient practices and cutting-edge scientific research.

Oral Presentations🎤

Professor Xing is a sought-after speaker at national and international conferences, where he shares his expertise on liver diseases and the integration of Traditional Chinese Medicine with modern bioinformatics. His presentations are well-received by the scientific community, as they often provide insights into innovative treatments and the application of TCM in complex diseases.

Tasks Completed as a Researcher🔑

Throughout his career, Professor Xing has played a pivotal role in over 20 major research projects at the national, provincial, and municipal levels, including the 11th, 12th, and 13th Five-Year Plan initiatives. His contributions to these projects have led to advancements in both the understanding and treatment of liver diseases, particularly through the integration of TCM with modern medical techniques.

Success Factors🏆

Professor Xing’s success can be attributed to his dedication to interdisciplinary research, combining Traditional Chinese Medicine with modern bioinformatics and material sciences. His ability to innovate, mentor young researchers, and continuously advance the field of liver disease treatments sets him apart as a leading figure in medical research.

Publications & Laboratory Experience🧪

With a focus on clinical and laboratory-based research, Professor Xing’s contributions have significantly advanced the understanding of liver diseases. His work in bioinformatics, nanocarriers, and network pharmacology offers new insights into how liver diseases can be treated using TCM-based methodologies, particularly at the molecular level. His publications serve as critical resources for future researchers in these fields.

📖Publications:

Paper Title: ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis

  • Authors: Yang, H., Wang, W., Xiao, J., Xu, L., Xing, Y.
  • Journal: Biomaterials
  • Year: 2025

Paper Title: Competitive adsorption of microRNA-532-3p by circular RNA SOD2 activates Thioredoxin Interacting Protein/NLR family pyrin domain containing 3 pathway and promotes pyroptosis of non-alcoholic fatty hepatocytes

  • Authors: Chen, F., Xing, Y., Chen, Z., Luo, F., Cai, Q.
  • Journal: European Journal of Medical Research
  • Year: 2024

Paper Title: Woman with epigastric pain after massage

  • Authors: Zhong, Z., Xing, Y., Wu, Y., Guo, S.
  • Journal: JACEP Open
  • Year: 2024

Paper Title: From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients

  • Authors: Huang, F., Lyu, B., Xie, F., Tong, G., Fengping, X.
  • Journal: Frontiers in Microbiology
  • Year: 2024

Paper Title: A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment

  • Authors: Chen, M., Huang, F., Chen, B., Zhou, H., Tong, G.
  • Journal: Biomedicine and Pharmacotherapy
  • Year: 2023